Principal Financial Group Inc Madrigal Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

$162 Billion
Q1 2024

A detailed history of Principal Financial Group Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 4,002 shares of MDGL stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,002

Previous 3,875 3.28%

Holding current value

$1.11 Million

Previous $896,000 19.2%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$171.37 - $283.23 $21,763 - $35,970	127 Added 3.28%	4,002 $1.07 Million
Q4 2023 Feb 07, 2024	BUY	$120.4 - $237.13 $17,096 - $33,672	142 Added 3.8%	3,875 $896,000
Q3 2023 Nov 02, 2023	SELL	$146.04 - $225.78 $11,391 - $17,610	-78 Reduced 2.05%	3,733 $545,000
Q2 2023 Aug 07, 2023	SELL	$203.88 - $312.0 $24,261 - $37,128	-119 Reduced 3.03%	3,811 $880,000
Q1 2023 May 09, 2023	SELL	$231.06 - $307.08 $61,693 - $81,990	-267 Reduced 6.36%	3,930 $952,000

Q4 2022 Feb 09, 2023	BUY	$58.39 - $296.54 $21,370 - $108,533	366 Added 9.55%	4,197 $1.22 Million
Q3 2022 Nov 09, 2022	SELL	$60.57 - $79.51 $3,937 - $5,168	-65 Reduced 1.67%	3,831 $249,000
Q2 2022 Aug 10, 2022	BUY	$58.04 - $100.2 $102,034 - $176,151	1,758 Added 82.23%	3,896 $279,000
Q1 2022 May 09, 2022	BUY	$55.89 - $101.89 $119,492 - $217,840	2,138 New	2,138 $210,000
Q4 2021 Feb 09, 2022	SELL	$72.34 - $95.09 $230,330 - $302,766	-3,184 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$78.35 - $105.02 $40,350 - $54,085	-515 Reduced 13.92%	3,184 $254,000
Q2 2021 Aug 10, 2021	SELL	$97.2 - $137.59 $160,088 - $226,610	-1,647 Reduced 30.81%	3,699 $360,000
Q1 2021 May 10, 2021	SELL	$108.54 - $125.2 $6,620 - $7,637	-61 Reduced 1.13%	5,346 $625,000
Q4 2020 Feb 08, 2021	BUY	$110.06 - $133.7 $240,040 - $291,599	2,181 Added 67.61%	5,407 $601,000
Q3 2020 Nov 06, 2020	SELL	$99.78 - $124.21 $15,565 - $19,376	-156 Reduced 4.61%	3,226 $383,000
Q2 2020 Aug 05, 2020	BUY	$60.13 - $125.71 $203,359 - $425,151	3,382 New	3,382 $383,000
Q1 2020 May 12, 2020	SELL	$66.76 - $93.49 $154,883 - $216,896	-2,320 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$84.28 - $118.5 $195,529 - $274,920	2,320 New	2,320 $211,000
Q3 2019 Nov 13, 2019	SELL	$84.4 - $106.53 $190,237 - $240,118	-2,254 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$91.13 - $142.5 $3,189 - $4,987	35 Added 1.58%	2,254 $236,000
Q1 2019 May 10, 2019	BUY	$103.48 - $143.84 $18,315 - $25,459	177 Added 8.67%	2,219 $278,000
Q4 2018 Feb 14, 2019	SELL	$94.77 - $215.54 $688,314 - $1.57 Million	-7,263 Reduced 78.05%	2,042 $230,000
Q3 2018 Nov 14, 2018	BUY	$207.3 - $300.31 $115,258 - $166,972	556 Added 6.36%	9,305 $1.99 Million
Q2 2018 Aug 13, 2018	BUY	$101.55 - $313.9 $888,460 - $2.75 Million	8,749 New	8,749 $0

Others Institutions Holding MDGL

# of Institutions

315

Shares Held

20M

Call Options Held

824K

Put Options Held

1.04M

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $4.73B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Madrigal Pharmaceuticals, Inc. Transaction History